Pharmacologic treatments for covid-19 patients

Nirmatrelvir/ritonavir vs Placebo


Outpatients

Forest plots
(last update: 2022-03-17)

Summary of findings
(last update: 2022-09-27)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=777

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
NCT04960202
EPIC-HR
Hammond J, N Engl J Med, 2022
Full text
Commentary
Private

Nirmatrelvir/ritonavir

Placebo

RCT Outpatients with confirmed COVID-19 (mild) treated by 343 centers in 21 countries N=2246
Some concerns
Details

Full description